+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Haloperidol an Alzheimer's disease



Haloperidol an Alzheimer's disease



American Journal of Psychiatry 156(12): 2019-2020




(PDF emailed within 1 workday: $29.90)

Accession: 046210295

Download citation: RISBibTeXText

PMID: 10588430


Related references

Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences 9(4): 591-593, 1998

A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease. Archives of Neurology 46(8): 854-857, 1989

Low dose oral haloperidol and blood levels in Alzheimer's disease: a preliminary study. Psychopharmacology Bulletin 28(2): 169-173, 1992

Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine. International Journal of Neuropsychopharmacology 9(5): 507-516, 2005

Antiaggressive effect of cyproterone versus haloperidol in Alzheimer's disease: a randomized double-blind pilot study. Journal of Clinical Psychiatry 68(3): 439-444, 2007

Inhibition of beta-amyloid formation by haloperidol: a possible mechanism for reduced frequency of Alzheimer's disease pathology in schizophrenia. Journal of Neurochemistry 68(1): 333-336, 1997

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. American Journal of Psychiatry 155(11): 1512-1520, 1998

The plasma haloperidol and reduced haloperidol concentrations in chinese schizophrenic patients relationship between reduced haloperidol haloperidol ratio and red blood cell haloperidol reductase activity. Human Psychopharmacology 7(2): 123-128, 1992

Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease. Alzheimer Disease and Associated Disorders 14(4): 212-215, 2001

Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease. Psychopharmacology Bulletin 35(2): 83-96, 2002

Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology 52(9): 1839-1844, 1999

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease. International Journal of Geriatric Psychiatry 26(9): 937-943, 2011

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia 7(3): 263-269, 2012

First episodes of behavioral symptoms in Alzheimer's disease patients at age 90 and over, and early-onset Alzheimer's disease: comparison with senile dementia of Alzheimer's type. Psychiatry and Clinical Neurosciences 59(6): 730-735, 2006